These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1876009)

  • 61. The effect of implementing a more comprehensive screening for substance use among pregnant women in North Carolina.
    Clark KA; Dawson S; Martin SL
    Matern Child Health J; 1999 Sep; 3(3):161-6. PubMed ID: 10746755
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Women in a prenatal care/substance abuse treatment program: links between domestic violence and mental health.
    Martin SL; Kilgallen B; Dee DL; Dawson S; Campbell J
    Matern Child Health J; 1998 Jun; 2(2):85-94. PubMed ID: 10728264
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hypertension and pulmonary oedema associated with ketamine administration in a patient with a history of substance abuse.
    Murphy JL
    Can J Anaesth; 1993 Feb; 40(2):160-4. PubMed ID: 8443855
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cocaine and pregnant women: a hospital study.
    Reddin P; Schlimmer B; Mitchell C
    Iowa Med; 1991 Sep; 81(9):374-6. PubMed ID: 1743927
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cocaine abuse in a high risk obstetrical population.
    Keller S; Niebyl J
    Iowa Med; 1993 Apr; 83(4):153-5. PubMed ID: 8468153
    [No Abstract]   [Full Text] [Related]  

  • 66. Cocaine and marijuana use during pregnancy by women intending and not intending to breast-feed.
    Frank DA; Bauchner H; Zuckerman BS; Fried L
    J Am Diet Assoc; 1992 Feb; 92(2):215-7. PubMed ID: 1310702
    [No Abstract]   [Full Text] [Related]  

  • 67. Cocaine use during pregnancy: implications for physicians.
    Aronson RA; Hunt LH
    Wis Med J; 1990 Mar; 89(3):105-10. PubMed ID: 2321404
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Substance abuse patterns in pregnant women.
    Knisely JS; Spear ER; Green DJ; Christmas JT; Schnoll SH
    NIDA Res Monogr; 1990; 105():280-1. PubMed ID: 1876009
    [No Abstract]   [Full Text] [Related]  

  • 69. Management of drug dependency, overdose, and withdrawal in the obstetric patient.
    Thorp JM
    Obstet Gynecol Clin North Am; 1995 Mar; 22(1):131-42. PubMed ID: 7784035
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Substance abuse in pregnancy.
    Feng T
    Curr Opin Obstet Gynecol; 1993 Feb; 5(1):16-23. PubMed ID: 8425031
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role of biologic markers in epidemiologic studies of prenatal drug exposure: issues in study design.
    Bracken MB; Leaderer B; Belanger K
    NIDA Res Monogr; 1992; 117():41-60. PubMed ID: 1620210
    [No Abstract]   [Full Text] [Related]  

  • 72. Perinatal substance abuse.
    Miller WH; Hyatt MC
    Am J Drug Alcohol Abuse; 1992; 18(3):247-61. PubMed ID: 1415083
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Epidemiology and health consequences of drug abuse among pregnant women.
    Khalsa JH; Gfroerer J
    Semin Perinatol; 1991 Aug; 15(4):265-70. PubMed ID: 1948137
    [No Abstract]   [Full Text] [Related]  

  • 74. Cocaine: clinical pharmacology and toxicology.
    Farrar HC; Kearns GL
    J Pediatr; 1989 Nov; 115(5 Pt 1):665-75. PubMed ID: 2681634
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.